• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Intraurethral prostaglandin improves quality of vacuum erection therapy.

作者信息

John H, Lehmann K, Hauri D

机构信息

Urologic Clinic, University Hospital Zurich, Switzerland.

出版信息

Eur Urol. 1996;29(2):224-6.

PMID:8647152
Abstract

OBJECTIVE

The aim of this study was to investigate whether intraurethral prostaglandin E1 (PGE1) improves vacuum-induced penile rigidity.

METHODS

Nineteen patients with a mean age of 55 years (range 30-66 years) complaining of erectile dysfunction for 24 months (range 3-156 months) were investigated. The penile diameter was measured and a mark was made 50 mm proximal of the coronary sulcus on the flaccid penis. Twenty micrograms of liquid PGE1 (pH 4.5; 308 mosm/l) were instilled intraurethrally; thereafter the meatus was occluded for 10 min. Penile diameter and increase in length of the initially 50-mm line were measured with both pure vacuum-induced erection as well as combined with PGE1.

RESULTS

The vacuum erection device alone lengthened the distance by 26 mm (range 18-64 mm) and the diameter by 4 mm (range 2-10 mm). Combined with PGE1, 36 mm (range 27-70 mm; p = 0.016) and 7 mm (range 2-11 mm; p = 0.04) were found, respectively.

CONCLUSION

We conclude that PGE1 significantly increases vacuum-induced tumescence. Optimized pharmacological preparations for intraurethral application are a new way to further improve vacuum-assisted erection.

摘要

相似文献

1
Intraurethral prostaglandin improves quality of vacuum erection therapy.
Eur Urol. 1996;29(2):224-6.
2
Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.长期海绵体内注射治疗后夜间阴茎勃起活动无变化。
J Urol. 2001 Mar;165(3):830-2; discussion 832-3.
3
Comparison of intraurethral liposomal and intracavernosal prostaglandin-E1 in the management of erectile dysfunction.尿道内脂质体与海绵体内前列腺素E1治疗勃起功能障碍的比较。
Br J Urol. 1998 Mar;81(3):441-4. doi: 10.1046/j.1464-410x.1998.00522.x.
4
[Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].实践中经尿道应用前列地尔治疗器质性勃起功能障碍:一项多中心临床监测研究(非干预性调查)
Arzneimittelforschung. 2007;57(6):299-308.
5
Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.前列腺素E1联合酚妥拉明治疗勃起功能障碍
Int J Impot Res. 1996 Mar;8(1):5-7.
6
[The use of PGE1 in the treatment of erectile deficiency].[前列腺素E1在勃起功能障碍治疗中的应用]
Acta Biomed Ateneo Parmense. 1996;67(1-2):49-53.
7
Combining intracavernous injection and external vacuum as treatment for erectile dysfunction.联合海绵体内注射与体外真空疗法治疗勃起功能障碍。
J Urol. 1995 May;153(5):1476-7.
8
Design and evaluation of prostaglandin E1 (PGE1) intraurethral liquid formulation employing self-microemulsifying drug delivery system (SMEDDS) for erectile dysfunction treatment.采用自微乳化药物递送系统(SMEDDS)的前列腺素E1(PGE1)尿道内液体制剂用于治疗勃起功能障碍的设计与评价
Biol Pharm Bull. 2008 Apr;31(4):668-72. doi: 10.1248/bpb.31.668.
9
Intraurethral application of alprostadil in patients with failed inflatable penile prosthesis.前列地尔经尿道应用于可膨胀阴茎假体植入失败的患者。
J Urol. 2000 Mar;163(3):785-7.
10
Prostaglandin E1 in the therapy of erectile deficiency.
Acta Eur Fertil. 1989 Sep-Oct;20(5):305-8.

引用本文的文献

1
Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study.口服治疗失败后,局部应用前列地尔与磷酸二酯酶-5抑制剂联合治疗勃起功能障碍患者:一项前瞻性、双臂、开放标签、非随机研究。
Int J Impot Res. 2022 Mar;34(2):164-171. doi: 10.1038/s41443-020-00400-9. Epub 2021 Jan 22.
2
Combination therapy for erectile dysfunction: an update review.勃起功能障碍的联合治疗:更新综述。
Asian J Androl. 2011 May;13(3):382-90. doi: 10.1038/aja.2011.2. Epub 2011 Mar 21.
3
Looking to the future for erectile dysfunction therapies.
展望勃起功能障碍治疗的未来。
Drugs. 2008;68(2):231-50. doi: 10.2165/00003495-200868020-00006.
4
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?勃起功能障碍治疗方案的比较性综述:何种治疗适用于何种患者?
Drugs. 2005;65(12):1621-50. doi: 10.2165/00003495-200565120-00003.